ONCAlert | 2018 ASCO Annual Meeting
Videos  >  

Valuable Endpoints Beyond OS in Ovarian Cancer

Maurie Markman, MD
Published Online:3:47 PM, Thu November 30, 2017

Maurie Markman, MD, president of medicine and science, Cancer Treatment Centers of America, discusses valuable endpoints beyond overall survival (OS) that can be used in ovarian cancer clinical trials.
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.